Stockscreener 앱 받기
95.57
5.47%
-5.53
시간 외 거래:
95.57
Revvity Inc 주식(RVTY)의 최신 뉴스
Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026 - MSN
Revvity boosts momentum at SLAS2026 with full session lineup - Traders Union
Optical Preclinical Imaging Market size to hit $982.8 Million - openPR.com
Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization - GlobeNewswire Inc.
Revvity showcases industry insights at SLAS2026 opening - Traders Union
Winners Losers: Can Revvity Inc outperform in the next rally2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Diamond Hill Capital Management Inc. Acquires New Holdings in Revvity Inc. $RVTY - MarketBeat
Downgrade Watch: Is Revvity Inc showing insider buyingInsider Buying & AI Forecasted Stock Moves - baoquankhu1.vn
Revvity stock rating reiterated at Overweight by KeyBanc - Investing.com Nigeria
Assessing Revvity (RVTY) Valuation After New SLAS2026 Lab Automation Launches - Sahm
Momentum Shift: Is Revvity Inc impacted by rising ratesQuarterly Earnings Report & Short-Term High Return Ideas - baoquankhu1.vn
Revvity (RVTY) Deepens AI And Buybacks Strategy: Is Diagnostics Now Its Core Value Engine? - simplywall.st
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 - Yahoo Finance
Truist Financial Corp Decreases Stake in Revvity Inc. $RVTY - MarketBeat
Revvity (RVTY) Receives a Buy from UBS - The Globe and Mail
Behavioral Patterns of RVTY and Institutional Flows - Stock Traders Daily
Revvity Inc.: How a Quiet Lab-Tech Powerhouse Is Rewiring the Future of Diagnostics and Drug Discove - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (THC), Revvity (RVTY) and Biogen (BIIB) - The Globe and Mail
Cowen & Co. Maintains Hold on Revvity (RVTY) Feb 03, 2026 - Meyka
Analysts Offer Insights on Healthcare Companies: Revvity (RVTY) and Aktis Oncology, Inc. (AKTS) - The Globe and Mail
Revvity stock price target raised to $124 from $120 at TD Cowen - Investing.com Canada
Revvity stock rating reiterated at Overweight by KeyBanc By Investing.com - Investing.com South Africa
JPMorgan Chase & Co. Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
JP Morgan Raises Revvity (RVTY) Price Target to $105.00 | RVTY S - GuruFocus
Revvity: Close To A Buy, Not Quite There (NYSE:RVTY) - Seeking Alpha
How is Revvity's stock performance compared to other health care stocks? - MSN
Revvity (NYSE:RVTY) Shares Track S&P 500 as Index Benchmarks Hold - Kalkine Media
Here's Why Revvity (RVTY) is a Strong Momentum Stock - sharewise.com
Revvity stock price target raised to $124 from $120 at TD Cowen By Investing.com - Investing.com India
TD Cowen Maintains 'Buy' Rating on RVTY, Raises Price Target to $124 | RVTY Stock News - GuruFocus
Revvity (NYSE:RVTY) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
Transcript: Q 2026 Earnings Conference Call - Benzinga
Revvity (RVTY) Receives Price Target Boost from Evercore ISI Gro - GuruFocus
Barclays Maintains Overweight Rating on RVTY, Raises Price Targe - GuruFocus
Wells Fargo Raises Price Target for RVTY, Maintains Equal-Weight Rating | RVTY Stock News - GuruFocus
Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results - Benzinga
Wells Fargo & Company Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
Revvity (RVTY) Maintains Hold Rating, Price Target Raised to $10 - GuruFocus
Wells Fargo Adjusts Price Target on Revvity to $110 From $107 - marketscreener.com
TD Cowen Adjusts Revvity PT to $124 From $120 - marketscreener.com
Revvity, Inc. (NYSE:RVTY) Q4 2025 earnings call transcript - MSN
Revvity, Inc. (NYSE:RVTY) Q4 2025 Earnings Call Transcript - Insider Monkey
Baird Adjusts Price Target on Revvity to $129 From $123 - marketscreener.com
Raymond James Adjusts Price Target on Revvity to $132 From $115 - marketscreener.com
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter - Classic Rock 103.5 WIMZ
Evercore ISI Adjusts Price Target on Revvity to $118 From $112 - marketscreener.com
Barclays Adjusts Price Target on Revvity to $118 From $115 - marketscreener.com
Revvity (RVTY) One Off US$92.7m Loss Challenges Bullish Earnings Narratives - Sahm
Fund Flows: Whats the beta of Revvity Inc stockMarket Sentiment Summary & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Revvity Q4 2025 slides: EPS beats expectations, stock dips despite strong results - Investing.com Nigeria
Revvity Earnings Call: Solid Execution, Cautious 2026 Outlook - TipRanks
Is Revvity (RVTY) Attractive After Recent Share Price Weakness And DCF Valuation Gap - Yahoo Finance
Revvity: Q4 Earnings Snapshot - KHOU
Revvity Q4 2025 Earnings Call Transcript - MarketBeat
Revvity shares tick up after fourth-quarter results and guidance update - AlphaStreet
Research Alert: CFRA Maintains Buy Rating On Shares Of Revvity Inc. - 富途牛牛
Revvity Inc (RVTY) Q4 2025 Earnings Call Highlights: Surpassing EPS Guidance and Strategic ... By GuruFocus - Investing.com Canada
1.18%
자본화:
|
볼륨(24시간):